|
Volumn 139, Issue 2, 2001, Pages 254-260
|
A randomized trial of two levels of iron supplementation and developmental outcome in low birth weight infants
a,b,c a,b,c a,b,c a,b,c a,b,c a,b,c
c
HEALTH CANADA
(Canada)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CATALASE;
COPPER;
FERRITIN;
GLUTATHIONE PEROXIDASE;
HEMOGLOBIN;
HYDROGEN PEROXIDE;
IRON;
MALONALDEHYDE;
SUPEROXIDE DISMUTASE;
TRANSFERRIN;
ZINC;
ANTHROPOMETRY;
ARTICLE;
BLOOD LEVEL;
CLINICAL TRIAL;
COGNITION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIETARY INTAKE;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVITY;
ERYTHROCYTE FRAGILITY;
FOLLOW UP;
HEMOGLOBIN DETERMINATION;
HUMAN;
INFANT;
INFECTION;
IRON INTAKE;
IRON THERAPY;
LOW BIRTH WEIGHT;
MAJOR CLINICAL STUDY;
PERINATAL DEVELOPMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
|
EID: 0034900969
PISSN: 00223476
EISSN: None
Source Type: Journal
DOI: 10.1067/mpd.2001.115069 Document Type: Article |
Times cited : (52)
|
References (30)
|